Menu
GeneBe

rs3850625

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000069.3(CACNA1S):c.4615C>T(p.Arg1539Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.117 in 1,613,950 control chromosomes in the GnomAD database, including 12,268 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1539H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.090 ( 826 hom., cov: 33)
Exomes 𝑓: 0.12 ( 11442 hom. )

Consequence

CACNA1S
NM_000069.3 missense

Scores

2
7
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 7.71
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017214417).
BP6
Variant 1-201047168-G-A is Benign according to our data. Variant chr1-201047168-G-A is described in ClinVar as [Benign]. Clinvar id is 197021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-201047168-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CACNA1SNM_000069.3 linkuse as main transcriptc.4615C>T p.Arg1539Cys missense_variant 38/44 ENST00000362061.4
CACNA1SXM_005245478.4 linkuse as main transcriptc.4558C>T p.Arg1520Cys missense_variant 37/43

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CACNA1SENST00000362061.4 linkuse as main transcriptc.4615C>T p.Arg1539Cys missense_variant 38/441 NM_000069.3 P2

Frequencies

GnomAD3 genomes
AF:
0.0905
AC:
13769
AN:
152082
Hom.:
823
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0215
Gnomad AMI
AF:
0.262
Gnomad AMR
AF:
0.0809
Gnomad ASJ
AF:
0.0916
Gnomad EAS
AF:
0.0360
Gnomad SAS
AF:
0.193
Gnomad FIN
AF:
0.148
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.120
Gnomad OTH
AF:
0.0961
GnomAD3 exomes
AF:
0.116
AC:
29089
AN:
251466
Hom.:
2021
AF XY:
0.125
AC XY:
16929
AN XY:
135902
show subpopulations
Gnomad AFR exome
AF:
0.0205
Gnomad AMR exome
AF:
0.0958
Gnomad ASJ exome
AF:
0.0926
Gnomad EAS exome
AF:
0.0333
Gnomad SAS exome
AF:
0.210
Gnomad FIN exome
AF:
0.152
Gnomad NFE exome
AF:
0.118
Gnomad OTH exome
AF:
0.113
GnomAD4 exome
AF:
0.119
AC:
174449
AN:
1461750
Hom.:
11442
Cov.:
33
AF XY:
0.123
AC XY:
89401
AN XY:
727178
show subpopulations
Gnomad4 AFR exome
AF:
0.0183
Gnomad4 AMR exome
AF:
0.0955
Gnomad4 ASJ exome
AF:
0.0910
Gnomad4 EAS exome
AF:
0.0352
Gnomad4 SAS exome
AF:
0.211
Gnomad4 FIN exome
AF:
0.152
Gnomad4 NFE exome
AF:
0.119
Gnomad4 OTH exome
AF:
0.109
GnomAD4 genome
AF:
0.0905
AC:
13771
AN:
152200
Hom.:
826
Cov.:
33
AF XY:
0.0921
AC XY:
6851
AN XY:
74398
show subpopulations
Gnomad4 AFR
AF:
0.0214
Gnomad4 AMR
AF:
0.0806
Gnomad4 ASJ
AF:
0.0916
Gnomad4 EAS
AF:
0.0367
Gnomad4 SAS
AF:
0.193
Gnomad4 FIN
AF:
0.148
Gnomad4 NFE
AF:
0.120
Gnomad4 OTH
AF:
0.0960
Alfa
AF:
0.113
Hom.:
2784
Bravo
AF:
0.0809
TwinsUK
AF:
0.125
AC:
465
ALSPAC
AF:
0.127
AC:
490
ESP6500AA
AF:
0.0218
AC:
96
ESP6500EA
AF:
0.124
AC:
1065
ExAC
AF:
0.117
AC:
14232
Asia WGS
AF:
0.106
AC:
370
AN:
3478
EpiCase
AF:
0.119
EpiControl
AF:
0.120

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 10, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 30, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Malignant hyperthermia, susceptibility to, 5 Benign:3
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 05, 2018- -
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthFeb 05, 2024- -
Hypokalemic periodic paralysis, type 1 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Congenital myopathy 18 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Thyrotoxic periodic paralysis, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsAug 31, 2017- -
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.30
Cadd
Pathogenic
29
Dann
Pathogenic
1.0
DEOGEN2
Benign
0.15
T;D
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.97
D;D
MetaRNN
Benign
0.0017
T;T
MetaSVM
Benign
-0.92
T
MutationTaster
Benign
5.6e-8
P;P
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-7.1
D;D
REVEL
Benign
0.28
Sift
Uncertain
0.0080
D;D
Sift4G
Uncertain
0.023
D;D
Polyphen
0.74
.;P
Vest4
0.14
MPC
0.38
ClinPred
0.062
T
GERP RS
5.2
Varity_R
0.71
gMVP
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3850625; hg19: chr1-201016296; COSMIC: COSV62938023; COSMIC: COSV62938023; API